Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma: study protocol for a multicentric randomized controlled trial
We present a multicenter, unblinded superiority randomized controlled trial to compare SPECT/CT-aided SLNE versus standard SLNE in melanoma patients.DiscussionThe primary efficacy endpoint is distant metastasis-free survival. Secondary endpoints comprise overall survival, disease-free survival, rate of local relapses within the follow-up period (false-negative rate of sentinel lymph node), number of positive sentinel lymph nodes (sensitivity, false-positive rate), complication rate, quality of life, quality-adjusted life years, inpatient days, and overall costs during hospital stays.Trial registrationClinicalTrials.gov,NCT...
Source: Trials - February 4, 2019 Category: Research Source Type: clinical trials
Sentinel Lymph Node Identification in Patients With Breast Cancer Using SPECT/CT
Condition: Early-stage Breast Cancer Interventions: Device: lymphoscintigraphy; Device: Single Photon Emission Tomography Sponsor: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2018 Category: Research Source Type: clinical trials
